APA (7th ed.) Citation

Muñoz-Cerón, J., Vélez-Jiménez, K., Bohórquez-Valderrama, S., Rodríguez-Leyva, I., Hernández, N., Gallo-Eugenio, L., . . . Gómez-Barrera, D. (2026). Galcanezumab for the preventive treatment of episodic and chronic migraine in real life: A prospective multicenter study in Colombia and Mexico, including effects on anxiety and depression—on behalf of ASOLAC. Cephalalgia Reports, 9, 1. https://doi.org/10.1177/25158163261418597

Chicago Style (17th ed.) Citation

Muñoz-Cerón, Joe, et al. "Galcanezumab for the Preventive Treatment of Episodic and Chronic Migraine in Real Life: A Prospective Multicenter Study in Colombia and Mexico, Including Effects on Anxiety and Depression—on Behalf of ASOLAC." Cephalalgia Reports 9 (2026): 1. https://doi.org/10.1177/25158163261418597.

MLA (9th ed.) Citation

Muñoz-Cerón, Joe, et al. "Galcanezumab for the Preventive Treatment of Episodic and Chronic Migraine in Real Life: A Prospective Multicenter Study in Colombia and Mexico, Including Effects on Anxiety and Depression—on Behalf of ASOLAC." Cephalalgia Reports, vol. 9, 2026, p. 1, https://doi.org/10.1177/25158163261418597.